Joe Garcia

Company: University of Florida

Job title: Founder & Chief Executive Officer

Seminars:

DAMPening Innate Immunity-Mediated Inflammatory Injury & Fibrosis via the eNAMPT-Neutralizing ALT-100 mAb 4:45 pm

• Explore the MOA behind ALT-100 mAb, a monoclonal antibody targeting eNAMPT, to dampen innate immunity-mediated inflammatory injury and fibrosis • Delve into the interplay between DAMP signaling and innate immunity, highlighting how the inhibition of eNAMPT holds promise in mitigating inflammatory responses implicated in pulmonary fibrosis progression.Read more

day: Day Two

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences Beacon
Searchlight Intelligence

SEARCH

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.